Recombinant Human VEGF165: The Gold-Standard Growth Factor for Angiogenesis, Tissue Engineering, and Organoid Culture

Introduction: Why VEGF165 Matters

As cell biology research shifts from traditional two-dimensional monolayers toward complex three-dimensional models, organoids, and vascularized tissue constructs, one critical question dominates every experimental design: How do we recreate the signaling microenvironment that cells experience in vivo?

At the center of this challenge lies vascular endothelial growth factor (VEGF), the master regulator of angiogenesis and vascular homeostasis. Among the multiple VEGF splice variants, VEGF165 stands out as the most extensively studied, most biologically active, and most widely applied isoform in both research and therapeutic development. Whether you are expanding primary endothelial cells, building vascularized tissue-engineered scaffolds, differentiating stem cells toward hemogenic endothelium, or cultivating perfusable organoids, high-quality recombinant human VEGF165 is an indispensable tool.At EastMabBio, we manufacture GMP-grade recombinant human VEGF165 (Cat. No. Y04701) using advanced CHO mammalian expression systems, delivering the purity, potency, and consistency that demanding applications require.

What Is VEGF165?

VEGF165 is the predominant splice variant of the VEGF-A gene in humans. Comprising 165 amino acids, it retains both the receptor-binding domain and the heparin-binding domain, enabling it to interact with VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1) on endothelial cells while also binding to extracellular matrix components. This dual-binding capability makes VEGF165 uniquely effective at:

• Stimulating endothelial cell proliferation and migration

• Inducing capillary tube formation in vitro

• Promoting vascular permeability and neovascularization

• Supporting endothelial differentiation from stem and progenitor cells

• Enhancing cell survival under hypoxic or serum-deprived conditions

The signaling cascade is elegant in its simplicity: VEGF165 → VEGFR activation → endothelial cell activation → angiogenesis. Yet the quality of the recombinant protein used to trigger this cascade can mean the difference between reproducible data and experimental failure.

Critical Applications Driving Demand for VEGF165

1. Endothelial Cell Culture and Expansion

Primary human umbilical vein endothelial cells (HUVECs) and other endothelial lineages require VEGF165 for sustained proliferation and maintenance of phenotypic identity in serum-reduced or defined media. Without supplemental VEGF165, HUVECs rapidly lose their cobblestone morphology and angiogenic potential.

2. Angiogenesis Assays

Tube formation assays, scratch-wound healing assays, and Transwell migration assays all depend on VEGF165 as the chemotactic and mitogenic stimulus. Assay sensitivity and reproducibility are directly proportional to the bioactivity and purity of the VEGF165 used.

3. Stem Cell Differentiation

Directed differentiation of induced pluripotent stem cells (iPSCs) and mesenchymal stem cells (MSCs) toward endothelial or hemogenic lineages requires precisely timed VEGF165 signaling. Combined with factors such as bFGF, BMP4, and Activin A, VEGF165 guides the emergence of CD31⁺/VE-cadherin⁺ endothelial progenitors.

4. Organoid and 3D Culture

Vascularization remains a major bottleneck in organoid maturation. Supplementing cerebral, hepatic, or intestinal organoid media with VEGF165 promotes the self-organization of endothelial networks, improving nutrient delivery, metabolic waste removal, and overall organoid viability.

5. Tissue Engineering and Vascularized Scaffolds

In regenerative medicine, VEGF165 is essential for prevascularizing collagen, gelatin, or synthetic scaffolds prior to implantation. Sustained VEGF165 release from biomaterial constructs accelerates host vessel infiltration, reduces ischemic necrosis, and improves graft integration.

EastMabBio Recombinant Human VEGF165 (Y04701): Engineered for Reliability

EastMabBio addresses every one of these challenges through a purpose-built manufacturing and quality control platform.

CHO Mammalian Expression: Native-Like Structure and Function

Unlike bacterial expression systems that often produce insoluble inclusion bodies lacking proper disulfide bonds and glycosylation, our VEGF165 is expressed in CHO cells. This eukaryotic platform ensures:

• Correct protein folding and disulfide-linked homodimer formation

• Authentic post-translational modifications

• Native receptor-binding affinity and bioactivity

Verified by HUVEC Proliferation Assay

Every batch of EastMabBio VEGF165 is functionally validated using a HUVEC cell proliferation assay. The established ED₅₀ ranges from 0.2 to 5 ng/mL, confirming robust mitogenic activity comparable to leading international suppliers.

Ultra-Low Endotoxin

Our VEGF165 is manufactured and purified under stringent aseptic conditions, achieving endotoxin levels of ≤0.01 EU/μg—well below the industry standard of ≤1.0 EU/μg and safe even for sensitive primary cell applications.

Dual Purity Verification

Purity is confirmed by both SDS-PAGE and SEC-HPLC, consistently achieving ≥95% purity. SEC-HPLC additionally verifies the correct homodimeric assembly state, a critical determinant of biological activity.

Exceptional Batch-to-Batch Consistency

Produced under ISO 13485 medical device quality management systems and GMP-compliant manufacturing protocols, EastMabBio VEGF165 delivers the lot-to-lot consistency required for regulated research, preclinical development, and clinical-scale cell manufacturing.

Integrated Solutions Beyond VEGF165

EastMabBio offers a comprehensive portfolio of recombinant proteins to support vascular biology and advanced cell culture. Complementary products include bFGF/FGF-2, EGF, PDGF-BB, TGF-β1, Activin A, HGF, and extracellular matrix proteins such as Fibronectin and Laminin. For stem cell and organoid workflows, we also provide recombinant human insulin, transferrin, and specialized culture supplements.

Accelerate Your Angiogenesis Research with EastMabBio

Whether you are establishing tube formation assays, expanding HUVEC cultures, engineering vascularized scaffolds, or differentiating iPSCs toward functional endothelium, the quality of your VEGF165 directly impacts the reliability of your data and the translational potential of your research.

EastMabBio Recombinant Human VEGF165 (Y04701) combines CHO-derived authenticity, ultra-low endotoxin, verified HUVEC bioactivity, and ISO 13485/GMP manufacturing discipline to deliver a growth factor you can trust—batch after batch.

Visit www.eastmabbio.com  to request a sample, download the Certificate of Analysis, or speak with our technical team about your specific application requirements.